491 related articles for article (PubMed ID: 28433762)
1. Novel viral and host targets to cure hepatitis B.
Ko C; Michler T; Protzer U
Curr Opin Virol; 2017 Jun; 24():38-45. PubMed ID: 28433762
[TBL] [Abstract][Full Text] [Related]
2. HBV cure: why, how, when?
Levrero M; Testoni B; Zoulim F
Curr Opin Virol; 2016 Jun; 18():135-43. PubMed ID: 27447092
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis B: Are we close to a cure?
Loggi E; Vitale G; Conti F; Bernardi M; Andreone P
Dig Liver Dis; 2015 Oct; 47(10):836-41. PubMed ID: 26138799
[TBL] [Abstract][Full Text] [Related]
4. Virological Basis for the Cure of Chronic Hepatitis B.
Hu J; Cheng J; Tang L; Hu Z; Luo Y; Li Y; Zhou T; Chang J; Guo JT
ACS Infect Dis; 2019 May; 5(5):659-674. PubMed ID: 29893548
[TBL] [Abstract][Full Text] [Related]
5. Possible role of tocopherols in the modulation of host microRNA with potential antiviral activity in patients with hepatitis B virus-related persistent infection: a systematic review.
Fiorino S; Bacchi-Reggiani L; Sabbatani S; Grizzi F; di Tommaso L; Masetti M; Fornelli A; Bondi A; de Biase D; Visani M; Cuppini A; Jovine E; Pession A
Br J Nutr; 2014 Dec; 112(11):1751-68. PubMed ID: 25325563
[TBL] [Abstract][Full Text] [Related]
6. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.
Durantel D; Zoulim F
J Hepatol; 2016 Apr; 64(1 Suppl):S117-S131. PubMed ID: 27084032
[TBL] [Abstract][Full Text] [Related]
7. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic hepatitis B.
Loomba R; Liang TJ
Antivir Ther; 2007; 12 Suppl 3():H33-41. PubMed ID: 18284181
[TBL] [Abstract][Full Text] [Related]
9. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
10. Emerging drugs for the treatment of hepatitis B.
Fung J; Lai CL; Seto WK; Yuen MF
Expert Opin Emerg Drugs; 2016 Jun; 21(2):183-93. PubMed ID: 26940510
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma.
Honda M; Shirasaki T; Terashima T; Kawaguchi K; Nakamura M; Oishi N; Wang X; Shimakami T; Okada H; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Infect Dis; 2016 Apr; 213(7):1096-106. PubMed ID: 26621908
[TBL] [Abstract][Full Text] [Related]
12. New anti-hepatitis B virus drugs under development and evaluation.
Pan J; Tong S; Kang L; Tang J
Curr Opin Infect Dis; 2016 Dec; 29(6):632-638. PubMed ID: 27783030
[TBL] [Abstract][Full Text] [Related]
13. Novel stable HBV producing cell line systems for expression and screening antiviral inhibitor of hepatitis B virus in human hepatoma cell line.
Ogura N; Ogawa K; Watashi K; Ito T; Wakita T
Biochem Biophys Res Commun; 2018 Mar; 498(1):64-71. PubMed ID: 29481805
[TBL] [Abstract][Full Text] [Related]
14. Challenges to a Cure for HBV Infection.
Testoni B; Levrero M; Zoulim F
Semin Liver Dis; 2017 Aug; 37(3):231-242. PubMed ID: 28847034
[No Abstract] [Full Text] [Related]
15. Hepatitis B Virus and DNA Damage Response: Interactions and Consequences for the Infection.
Gómez-Moreno A; Garaigorta U
Viruses; 2017 Oct; 9(10):. PubMed ID: 29048354
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus receptors and molecular drug targets.
Verrier ER; Colpitts CC; Sureau C; Baumert TF
Hepatol Int; 2016 Jul; 10(4):567-73. PubMed ID: 26979861
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.
Kubo S; Takemura S; Tanaka S; Shinkawa H; Nishioka T; Nozawa A; Kinoshita M; Hamano G; Ito T; Urata Y
World J Gastroenterol; 2015 Jul; 21(27):8249-55. PubMed ID: 26217076
[TBL] [Abstract][Full Text] [Related]
18. Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.
Xia Y; Carpentier A; Cheng X; Block PD; Zhao Y; Zhang Z; Protzer U; Liang TJ
J Hepatol; 2017 Mar; 66(3):494-503. PubMed ID: 27746336
[TBL] [Abstract][Full Text] [Related]
19. Does antiviral therapy for chronic hepatitis B reduce the risk of hepatocellular carcinoma?
Abu-Amara M; Feld JJ
Semin Liver Dis; 2013 May; 33(2):157-66. PubMed ID: 23749672
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus-host interactions and novel targets for viral cure.
Ligat G; Verrier ER; Nassal M; Baumert TF
Curr Opin Virol; 2021 Aug; 49():41-51. PubMed ID: 34029994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
